Changes

Jump to navigation Jump to search
no edit summary
Line 616: Line 616:  
|'''''Splenic B-cell Lymphoma/Leukemia, Unclassifiable'''''||'''''Overview'''''||Snehal Patel
 
|'''''Splenic B-cell Lymphoma/Leukemia, Unclassifiable'''''||'''''Overview'''''||Snehal Patel
 
|SP
 
|SP
|PENDING
+
|Complete
 
|
 
|
 
|Malini to review
 
|Malini to review
Line 622: Line 622:  
|    Splenic Diffuse Red  Pulp Small B-cell Lymphoma||Disease||Snehal Patel
 
|    Splenic Diffuse Red  Pulp Small B-cell Lymphoma||Disease||Snehal Patel
 
|SP
 
|SP
|PENDING
+
|Complete
 
|
 
|
 
|Malini to review
 
|Malini to review
Line 788: Line 788:  
|Mantle Cell Lymphoma||Disease||Mahsa Khanlari
 
|Mantle Cell Lymphoma||Disease||Mahsa Khanlari
 
|SP
 
|SP
|PENDING
+
|PENDING - due 8/15/20
 
|
 
|
 
|
 
|
Line 794: Line 794:  
|    Leukemic Non-Nodal  Mantle Cell Lymphoma||Disease||Mahsa Khanlari
 
|    Leukemic Non-Nodal  Mantle Cell Lymphoma||Disease||Mahsa Khanlari
 
|SP
 
|SP
|PENDING
+
|PENDING - due 8/31/20
 
|
 
|
 
|
 
|
Line 800: Line 800:  
|    In Situ Mantle Cell  Neoplasia||Disease||Mahsa Khanlari
 
|    In Situ Mantle Cell  Neoplasia||Disease||Mahsa Khanlari
 
|SP
 
|SP
|PENDING
+
|PENDING - due 8/15/20
 
|
 
|
 
|
 
|

Navigation menu